Showing 1 - 9 results of 9 for search 'Shuxia QIN', query time: 0.04s Refine Results
  1. 1
    Relationships between dietary habits and blood pressure in employees of a chemical enterprise in Gansu Province

    Relationships between dietary habits and blood pressure in employees of a chemical enterprise in Gansu Province by Lu WANG, Qi LIANG, Shuxia QIN

    Published 2023-09-01
    Get full text
    Article
  2. 2
    Estimated projection of incidence and mortality of alcohol-related liver disease in China from 2022 to 2040: a modeling study

    Estimated projection of incidence and mortality of alcohol-related liver disease in China from 2022 to 2040: a modeling study by Meiyu Wu, Shuxia Qin, Chongqing Tan, Sini Li, Ouyang Xie, Xiaomin Wan

    Published 2023-07-01
    Get full text
    Article
  3. 3
    Cost-Effectiveness of Pembrolizumab Plus Chemotherapy as First-Line Therapy for Advanced Oesophageal Cancer

    Cost-Effectiveness of Pembrolizumab Plus Chemotherapy as First-Line Therapy for Advanced Oesophageal Cancer by Meiyu Wu, Meiyu Wu, Shuxia Qin, Shuxia Qin, Liting Wang, Liting Wang, Chongqing Tan, Chongqing Tan, Ye Peng, Ye Peng, Xiaohui Zeng, Xia Luo, Xia Luo, Lidan Yi, Lidan Yi, Xiaomin Wan, Xiaomin Wan

    Published 2022-05-01
    Get full text
    Article
  4. 4
    Economic Evaluation of Dapagliflozin in the Treatment of Patients With Heart Failure: A Systematic Review

    Economic Evaluation of Dapagliflozin in the Treatment of Patients With Heart Failure: A Systematic Review by Meiyu Wu, Meiyu Wu, Shuxia Qin, Shuxia Qin, Liting Wang, Liting Wang, Chongqing Tan, Chongqing Tan, Ye Peng, Ye Peng, Xiaohui Zeng, Xia Luo, Xia Luo, Lidan Yi, Lidan Yi, Xiaomin Wan, Xiaomin Wan

    Published 2022-04-01
    Get full text
    Article
  5. 5
    First-line systemic treatment strategies for unresectable hepatocellular carcinoma: A cost-effectiveness analysis

    First-line systemic treatment strategies for unresectable hepatocellular carcinoma: A cost-effectiveness analysis by Liting wang, Ye Peng, Shuxia Qin, Xiaomin Wan, Xiaohui Zeng, Sini Li, Qiao Liu, Chongqing Tan

    Published 2023-01-01
    Get full text
    Article
  6. 6
    First-line systemic treatment strategies for unresectable hepatocellular carcinoma: A cost-effectiveness analysis.

    First-line systemic treatment strategies for unresectable hepatocellular carcinoma: A cost-effectiveness analysis. by Liting Wang, Ye Peng, Shuxia Qin, Xiaomin Wan, Xiaohui Zeng, Sini Li, Qiao Liu, Chongqing Tan

    Published 2023-01-01
    Get full text
    Article
  7. 7
    Benefit-to-harm ratio and cost-effectiveness of government-recommended gastric cancer screening in China: A modeling study

    Benefit-to-harm ratio and cost-effectiveness of government-recommended gastric cancer screening in China: A modeling study by Shuxia Qin, Xuehong Wang, Sini Li, Sini Li, Chongqing Tan, Xiaohui Zeng, Meiyu Wu, Ye Peng, Liting Wang, Xiaomin Wan

    Published 2022-08-01
    Get full text
    Article
  8. 8
    Cost-Effectiveness of Ipilimumab Plus Anti-PD-1 Therapy Versus Ipilimumab Alone in Patients With Metastatic Melanoma Resistant to Anti-PD-(L)1 Monotherapy

    Cost-Effectiveness of Ipilimumab Plus Anti-PD-1 Therapy Versus Ipilimumab Alone in Patients With Metastatic Melanoma Resistant to Anti-PD-(L)1 Monotherapy by Ye Peng, Xiaohui Zeng, Liubao Peng, Qiao Liu, Lidan Yi, Xia Luo, Sini Li, Liting Wang, Shuxia Qin, Xiaomin Wan, Chongqing Tan

    Published 2021-11-01
    Get full text
    Article
  9. 9
    Sintilimab Plus Bevacizumab Biosimilar Versus Sorafenib as First-Line Treatment for Unresectable Hepatocellular Carcinoma: A Cost-Effectiveness Analysis

    Sintilimab Plus Bevacizumab Biosimilar Versus Sorafenib as First-Line Treatment for Unresectable Hepatocellular Carcinoma: A Cost-Effectiveness Analysis by Ye Peng, Xiaohui Zeng, Liubao Peng, Qiao Liu, Lidan Yi, Xia Luo, Sini Li, Liting Wang, Shuxia Qin, Xiaomin Wan, Chongqing Tan

    Published 2022-02-01
    Get full text
    Article

Search Tools: